Novo Nordisk and Eli Lilly Slide as Biden Blasts Weight-Loss Drug Prices [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
President Joe Biden and Senator Bernie Sanders called out the companies in an op-ed for the cost of their medicines. Biden and Sanders said big pharmaceutical firms of charge "outrageous prices" for prescription drugs, and cited the cost of weight-loss drugs made by Novo Nordisk and Eli Lilly. Biden and Sanders warned they would take action if Novo Nordisk and other pharmaceutical companies do not “substantially lower" prescription drug prices. Novo Nordisk ( NVO American depositary receipts (ADRs) and Eli Lilly ( LLY ) shares lost ground Tuesday after U.S. President Joe Biden and Senator Bernie Sanders called out the companies in an op-ed for the cost of their medicines. Sanders and Biden wrote that the pharmaceutical industry charges “outrageous prices” for prescription drugs, and cited popular weight-loss treatments including Novo Nordisk's Wegovy, and Mounjaro from Eli Lilly, calling their costs “unconscionably high.” Biden, Sanders Call on Novo Nordisk and Others To Low
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Study links GLP-1 drugs, metformin to lower risk of certain cancers [Seeking Alpha]Seeking Alpha
- Diabetes patients using Ozempic, other treatments instead of insulin have lower cancer risk, study finds [FOX News]FOX News
- Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures [Yahoo! Finance]Yahoo! Finance
- Weight-Loss Drugs Linked With Lower Risk of Obesity-Related Cancers [BNN Bloomberg (Canada)]BNN Bloomberg
- Diabetes patients on GLP-1 treatments instead of insulin have lower cancer risk, study shows [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
NVO
Earnings
- 5/3/24 - Beat
NVO
Sec Filings
- 7/2/24 - Form 6-K
- 6/26/24 - Form 6-K
- 6/24/24 - Form 6-K
- NVO's page on the SEC website